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Protocol
AbstrACt
Introduction The failure to follow-up pathology and 
medical imaging test results poses patient-safety risks 
which threaten the effectiveness, quality and safety of 
patient care. The objective of this project is to: (1) improve 
the effectiveness and safety of test-result management 
through the establishment of clear governance processes 
of communication, responsibility and accountability; 
(2) harness health information technology (IT) to inform 
and monitor test-result management; (3) enhance the 
contribution of consumers to the establishment of safe and 
effective test-result management systems.
Methods and analysis This convergent mixed-
methods project triangulates three multistage studies 
at seven adult hospitals and one paediatric hospital in 
Australia. Study 1 adopts qualitative research approaches 
including semistructured interviews, focus groups and 
ethnographic observations to gain a better understanding 
of test-result communication and management practices 
in hospitals, and to identify patient-safety risks which 
require quality-improvement interventions. Study 2 
analyses linked sets of routinely collected healthcare 
data to examine critical test-result thresholds and 
test-result notification processes. A controlled before-
and-after study across three emergency departments 
will measure the impact of interventions (including 
the use of IT) developed to improve the safety and 
quality of test-result communication and management 
processes. Study 3 adopts a consumer-driven approach, 
including semistructured interviews, and the convening 
of consumer-reference groups and community forums. 
The qualitative data will identify mechanisms to enhance 
the role of consumers in test-management governance 
processes, and inform the direction of the research and 
the interpretation of findings.
Ethics and dissemination Ethical approval has been 
granted by the South Eastern Sydney Local Health District 
Human Research Ethics Committee and Macquarie 
University. Findings will be disseminated in academic, 
industry and consumer journals, newsletters and 
conferences.
IntroduCtIon 
WHO, World Alliance for Patient Safety has 
identified poor test-result management as a 
high-priority patient-safety area.1 Systematic 
reviews in test-result follow-up have shown 
strengths and limitations of this study
 ► The description of multiple processes used to 
manage test results across seven adult hospitals 
and a children’s hospital will provide rich and unique 
comparative evidence about hospitals of different 
size, geographical location (rural, regional and 
metropolitan) and specialty.
 ► We will use an innovative data-driven approach 
to generate evidence about the impact of critical 
results notification thresholds on test-result follow-
up processes and outcomes across different patient 
groups.
 ► We will ensure consumer engagement across all 
stages of the study from inception to dissemination, 
and capture experiences and opinions of a range 
of health consumer representatives and front-line 
patients.
 ► Our quantitative analysis is limited to data related 
to patients admitted to hospital. We will be able to 
monitor readmissions across participating hospital 
sites. There are some consequences of failure to 
follow-up test results (eg, mortality after discharge 
or readmission to hospitals not involved in the study) 
that we will not be able to measure.
 ► Qualitative evaluation methods are often conducted 
with smaller samples which means that findings may 
not be readily generalisable to larger populations. 
Nevertheless, qualitative research findings will 
provide context-rich insights that can expand the 
scientific knowledge base. Our mixed-methods 
approach allows for triangulation and draws on the 
strengths of qualitative and quantitative approaches.
2 Dahm MR, et al. BMJ Open 2018;8:e020235. doi:10.1136/bmjopen-2017-020235
Open Access 
that pathology and imaging test results fail to be followed 
up for 20%–62% of inpatients, and for up to 75% of 
patients treated in an emergency department (ED).2 
Other research from a Sydney hospital showed that tests 
ordered on the day of patient discharge accounted for 
47% of missed test results, raising questions about the 
necessity and appropriateness of ordering tests whose 
results are most likely never reviewed.3 Poor test-result 
follow-up can have major consequences for quality of 
care, including missed diagnoses and suboptimal patient 
outcomes.4 The urgency of the problem was highlighted 
by the US Emergency Care Research Institute’s 2017 
report on patient-safety concerns for healthcare organi-
sations. The report listed data-integrity failures associated 
with health information systems, poor care coordination 
across levels of care and test-result reporting problems 
among their top 10 patient-safety concerns for 2017.5 
Information technology (IT) has a key role to play in the 
communication and follow-up of test results.6 However, 
new models of test management supported by IT can 
only succeed if they are part of robust clinical governance 
processes which can underpin safe test management.7 
Effective solutions must engage all stakeholders to arrive 
at decisions about who needs to receive the test results, 
how and when the results are communicated, and how 
they are acknowledged and acted on.8 Meeting these chal-
lenges requires the establishment of robust and resilient 
partnerships between managers, clinicians, pathology 
and medical imaging departments, and must include the 
involvement of consumers.
the establishment of effective test-result management 
systems in hospitals
Tackling the issue of test-result follow-up goes hand-in-
hand with the establishment of an integrated governance 
structure ensuring the safety of patient care. Effective clin-
ical governance systems involve the clear delineation of 
responsibilities, communication and workforce account-
ability, along with systems to monitor progress and deal 
with any risks or impediments.9 Many clinicians describe 
existing test-result management systems as inefficient and 
chaotic.10 There is a lack of clarity about responsibilities 
and accountabilities of ordering versus treating clinicians 
for test-result follow-up, especially in relation to attending 
to time-critical results.8 11
Clear guidelines and standards for test-result follow-up
Pathology and medical imaging services perform a major 
role in the delivery of patient care by ensuring reliable and 
accurate results are delivered in a timely fashion to inform 
clinical management decisions.1 One of the main sources 
of problems is errors in the reporting phase of the labo-
ratory process, when test-result information is communi-
cated to the requesting (or referring) clinician. Such errors 
are often due to a lack of agreed standards or guidelines 
among laboratories, medical imaging departments, hospi-
tals and other healthcare settings about what are critical, 
unexpected or significantly abnormal results, and when and 
how these results should be communicated to the respon-
sible clinician.12 13 Definitions of thresholds for critical tests 
and subsequent notification processes for critical pathology 
and imaging test results are largely based on consensus and 
expert opinions, and lack a rigorous evidence base.12 Good 
practice recommendations in this area emphasise the impor-
tance of clear definitions of key terms, the need for agreed 
alert thresholds and time frames, and specified procedures 
for fail-safe communication of test results that pose a crit-
ical or significant risk to patient safety.8 12 13 This lack of stan-
dards is currently under review by a collaboration between 
the Royal College of Pathologists of Australasia (RCPA) and 
the Australian Association of Clinical Biochemists (AACB) 
which has established the Pathology Information, Termi-
nology and Units Standardisation programme.14 This new 
initiative aims to draw on existing evidence from pathology 
datasets to establish standardised pathology information 
structures and terminologies to improve recording, decision 
support and communication of laboratory information.
Harnessing It
Several electronic applications have been developed to 
support test-result management processes. These include 
systems that can track pending test results at hospital 
discharge,15 deliver result alerts to clinicians, act as 
safety nets in result notification16 or use tracking systems 
to document acknowledgement and clinical actions.6 
Intuitively, one would have expected the development 
of electronic systems to overcome problems associated 
with the existence of hospital data silos, yet poor inte-
gration of electronic systems has emerged as one of the 
most significant hazards to patient safety in Australia and 
internationally.17 At any one point in time, most hospi-
tals are unable to identify critical test results which have 
not been reviewed unless they conduct time-consuming 
and cumbersome audits involving paper (and electronic) 
records.18 In such cases, the identification of missed test 
results may well be too late to have any positive effect on 
patient safety.2 However, performing sophisticated data 
linkage provides opportunities for leveraging the vast 
quantities of information held in these existing datasets 
to support the monitoring of test-result follow-up, derive 
new evidence to establish clinically meaningful critical 
test-result thresholds and to identify the consequences of 
test-result notification practices.16 Sophisticated models 
developed for linking previously fragmented hospital 
databases within and across multiple hospitals have been 
used to successfully monitor key indicators of hospital 
performance, including test-ordering patterns, test-re-
sult turnaround times and to investigate the relationships 
between testing patterns and patient outcome measures 
such as patient length of stay and mortality.19
Enhancing the contribution of consumers in the test-
management process
Failure to inform patients of their test results can have 
devastating consequences for their health4 and has been 
described as legally indefensible in malpractice claims.20 
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Effective partnerships between patients and clinicians, 
and increased consumer engagement, have the reported 
benefits of making healthcare safer and better.21 22 This is 
relevant to test-result follow-up where patients can access 
their own appointment and personal information, and 
facilitate communication with health professionals by 
using secure electronic patient portals to access their elec-
tronic health records.23 However, major obstacles hinder 
the involvement of consumers, including a lack of educa-
tional tools and self-management guides outlining when 
it may be necessary to seek medical assistance.22 There is 
no consensus among clinicians regarding if, and when, 
patients should have access to their test results.24 Many 
clinicians report the need for consumer education and 
support tools if strategies such as the direct notification of 
results to consumers are instituted.25 This is contrasted by 
the views of many consumers who report they want access 
to their test results.26 It is crucial that consumers are 
involved in informing the development of any such strat-
egies and advise on the type of tools which may be most 
effective and acceptable to a wide spectrum of consumers.
This National Health and Medical Research Council 
(NHMRC)-funded  Partnership Project, undertaken in 
collaboration with the New South Wales (NSW) Health 
Pathology and the Australian Commission on Safety and 
Quality in Health Care (The Commission), will run from 
2016 to 2020 and aims to make a significant contribution 
to enhanced patient safety in Australia and internationally. 
This innovative and comprehensive mixed-methods project 
combines quantitative and qualitative research across three 
studies to assess if the introduction of health IT incorpo-
rating clearly defined standards of communication, respon-
sibility and accountability among pathology and medical 
imaging departments, hospital management and clinicians, 
and underpinned by consumer engagement will lead to 
improved safety and effectiveness of test-result follow-up 
practices.
The project’s three aims will be addressed in three 
studies:
Aim 1: to improve the effectiveness and safety of test-re-
sult management through the establishment of clear 
processes of communication, responsibility and account-
ability (study 1);
Aim 2: to harness health IT to inform and monitor 
test-result management (study 2);
Aim 3: to enhance the contribution of consumers to 
the establishment of safe and effective test-result manage-
ment systems (study 3).
MEtHods
Project design and setting
We will conduct a convergent mixed-methods27 project 
over a 5-year period concurrently collecting qualitative 
and quantitative data for triangulation and corrobora-
tion. Integrating complementary qualitative and quantita-
tive approaches will allow us to develop a more complete 
understanding of the complex issues surrounding test-re-
sult management and contribute to the evidence base to 
inform the development of interventions to enhance the 
safety and quality of test-result management.
The project will involve the Emergency Departments 
(EDs), intensive care units (ICUs) and general admission 
wards at eight hospitals in the Sydney Children’s Hospital 
Network, South Eastern Sydney (SES) and Illawarra 
Shoalhaven (IS) Local Health Districts  (LHDs) in NSW, 
Australia. In 2016, the study hospitals provided care to 
more than 340 000 ED presentations. Table 1 provides an 
overview of all hospital sites for this project, the number 
of presentations to each ED in 2016 and provision of ICU 
services.
research plan
Study 1
Aim: Improve the effectiveness and safety of test-result 
management through the establishment of clear processes 
of communication, responsibility and accountability.
We will adopt a problem-focused approach28 to map 
current test-management practices within our study sites, 
to develop an organisational test-result management clin-
ical governance checklist and to implement improved 
test-management governance processes.
Table 1 ED presentations for 2016 and provision of ICU services across study hospital sites in SES LHD and IS LHD
SES LHD and SCHN ED presentations 2016* ICU IS LHD ED presentations 2016* ICU
Prince of Wales Hospital 54 443 ✓ Shellharbour Hospital 29 479 –
Royal Hospital for Women, Sydney Not applicable ✓† Shoalhaven Hospital 38 039 ✓
St George Hospital 76 228 ✓ Wollongong Hospital 61 348 ✓
Sutherland Hospital 50 025 ✓
Sydney Children’s Hospital 36 700 ✓
Total 217 396 128 899
*Calculated using quarterly data of presentations to EDs (January–December 2016) via Bureau of Health Information interactive data portal 
Healthcare Observer.47
†Acute care service.
ED, emergency department; ICU, intensive care unit; IS, Illawarra Shoalhaven; LHD, Local Health District; SCHN, Sydney Children’s Hospital 
Network; SES, South Eastern Sydney.
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To map test-management practices to outline current 
levels of communication, responsibility and accountability, 
the research team will use a range of qualitative appraisal 
techniques including audio-recorded focus groups, inter-
views with up to 10 clinical staff, and ‘Think-Aloud’ work 
observations with up to four clinical staff within each of 
the EDs, ICUs, general admission wards, pathology labo-
ratories and medical imaging departments of the hospital 
study sites. Directors and nurse unit managers of the rele-
vant departments at the study hospitals will be provided 
with introductory recruitment letters, along with partici-
pant information sheets and consent forms to be distrib-
uted to potential participants.
Depending on the hospital size, two members of the 
research team will be present at each site for a duration 
of 2–5 days, when clinical staff will be invited to partici-
pate in interviews. Interviews are expected to last between 
20 and 30 min, focus groups up to 40 min. We antici-
pate that up to 50 interviews at each hospital site will be 
conducted for this part of the study (ie, ~10 staff for each 
department) to capture all levels of staff across manage-
rial and clinical hierarchies.
Questions for the semistructured interviews and focus 
groups will be exploratory, and are informed by current liter-
ature. They will cover aspects of test ordering, result notifica-
tion and acknowledgement, delineation of abnormal versus 
critical versus significant results and communication of test 
results to patients, and within and across wards, and hospi-
tals.8 28 29 Multimodal data will be collected in the form of 
observational field notes, audio recordings, photographs and 
other relevant artefacts. All audio recordings will be de-iden-
tified and transcribed. We will employ triangulation of data, 
undertake participant validation via member checking and 
involve multiple researchers in qualitative coding to ensure 
the trustworthiness of the qualitative data.30 Transcripts will 
be analysed inductively for emerging themes31–33 by at least 
two members of the research team and analysed iteratively 
using NVivo qualitative data analysis software (QSR Interna-
tional, V.11, 2015). Qualitative data will be used to identify, 
map and compare current test-management work processes 
(eg, documenting the communication channels used for 
alerting doctors to critical test results) in the laboratories 
and different clinical environments across hospitals.33
Differences in test-management practices between 
hospitals will be identified, and adherence to national and 
Figure 1 Data extraction and linkage outline. DRG, Diagnosis-related group; ED, emergency department; ICD, International 
Statistical Classification of Diseases and Related Health Problems; SNOMED, Systematized Nomenclature of Medicine.
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international recommendations and guidelines (where 
they exist) will be assessed to pinpoint evidence-practice 
gaps. These investigations will identify communication 
practices regarding:
 ► how test results of different levels of importance 
(eg, urgent, life threatening, critical but non-ur-
gent results, etc) are communicated to clinicians in 
different settings (eg, ED vs ICUs);
 ► how responsibility is managed (eg, identification of 
who is sent the test result, escalation procedures when 
a responsible medical officer is unavailable);
 ► accountability structures (eg, organisational level 
procedures to identify test results which have not 
been reviewed across defined periods).
A test-result management clinical governance checklist 
will draw on empirical evidence and will be developed 
through an iterative consultation process with our stake-
holders. Based on the findings of study 1, we will draft 
a proposal checklist to be shared for comments (eg, 
to identify specific areas for intervention) with clini-
cians, laboratory and management staff at the hospitals 
during a series of workshops and with consumers in 
our community forum (see the Study 3 section). Stake-
holder feedback will contribute to revisions of the check-
list and stakeholders will be engaged in the approval of 
the checklist. The aim of the checklist will be to provide 
clear guidance to hospitals regarding the standardisation 
of test-management practices which will reduce the risk 
of failure to follow-up test results. Individual organisa-
tions will be able to compare existing processes against 
the checklist to identify areas requiring revision and/or 
change. The checklist is a change facilitation artefact that 
will serve a dual role—first, as a purpose-designed frame-
work to direct the conduct of actions by the healthcare 
organisations,9 34 and second, as a translational research 
product which will be iteratively refined and developed 
for application in other healthcare settings (eg, general 
practice) across Australia and internationally.
Following on from the workshops, our research part-
ners in NSW Health Pathology and across the partic-
ipating hospitals will use the checklist to identify and 
deploy interventions aimed at improving the effectiveness 
and safety of test-result management within each organ-
isation. Interventions may include the introduction of 
alert thresholds (relating to when a test result is consid-
ered urgent or critical) for a specified range of critical 
laboratory test results (as identified by our partners). 
Further intervention may involve implementation 
changes related to recommended modes of communication 
(eg, fax, pager, telephone or electronic alert) and clinical 
governance processes (eg, escalation process in cases where 
a doctor is not available).
Study 2
Aim: Harness health IT to inform and monitor test-result 
management.
Study 2 employs a data-driven approach and advanced 
data-linkage techniques using routinely collected data 
from healthcare databases to inform and monitor test-re-
sult management. A retrospective longitudinal study will 
be conducted to inform the adoption of critical test-result 
thresholds and notification processes (eg, using an algo-
rithm to identify acute kidney injury (AKI)). A controlled 
before-and-after study across three EDs will be undertaken 
to measure the impact of interventions on the safety and 
quality of test results follow-up (eg, rates of result acknowl-
edgement or rates of result return after discharge). Inter-
ventions include the clinical governance checklist developed 
in study 1 and additional possible intervention(s) imple-
mented independently by NSW Health Pathology during 
the project period (eg, alert notification or clinical deci-
sion support systems).
Data linkage
Non-identifiable datasets from Laboratory Information 
System (LIS), hospital patient administration system 
(PAS), ED information system, ICU and Radiology Infor-
mation System (RIS) will be provided to the research team 
to create a dataset linking patient demographics, their 
clinical information, test results and health outcomes. 
Figure 1 provides examples of specific fields extracted 
from each dataset, along with a schematic of the data-
linkage process. Data will be rendered non-identifiable to 
the research team by staff within NSW Health Pathology, 
in such a way that a unique (quasi) patient ID will be 
generated which will be used to link different datasets.
The research team will conduct a data quality assess-
ment and analyse the data for accuracy, comparability, 
completeness, conformity, consistency, relevance, time-
liness, usability and validity.35 36 The initial dataset will 
cover the period from 1 January 2010 to 30 December 
2016. An annual data extract will then be made at the end 
of June in each year of the study, to provide the research 
team with all patient information from the previous year.
Retrospective longitudinal study
To aid our understanding of the relationships between crit-
ical test-result thresholds, subsequent notification proce-
dures, and a range of key process and outcome indicators, 
we will conduct a retrospective longitudinal study using 
Table 2 Power calculation for study to measure 
acknowledgement rate for critical test result
Acknowledgement rate
Before 45.0%
Percentage change +20.0%
After 54.0%
Number of critical tests to be reviewed per study 
period for each arm at each site (n)
700
Number of critical tests to be reviewed at each 
site (2n)
1400
Number of critical tests to be reviewed at three 
ED sites during the study period
4200
ED, emergency department.
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routinely collected healthcare data and apply robust multi-
level models.37 Working in consortium teams with our clin-
ical and scientific partners and focused on specific patient 
groups (eg, patients undergoing tests such as potassium or 
serum creatinine), we will identify patient cohorts whose 
results fall within and outside existing definitions of critical 
test results (drawing on the definitions identified in study 
1). For example, we will conduct a retrospective examina-
tion of laboratory identification of AKI which is acquired by 
approximately 13.3 million people globally, with mortality 
expected in 10%–15% of affected individuals.38 A lack of 
consensus around the definition of AKI has led to late iden-
tification and poor management of it leading to increased 
mortality, with hospital patients likely to be discharged with 
unrecognised AKI and others being managed inappropri-
ately.39 40 A standardised AKI algorithm was produced in the 
UK based on the serum creatinine changes described in the 
Kidney Disease: Improving Global Outcomes classification.39 
This was followed by an electronic patient-safety alert across 
hospitals in England.39 We propose to undertake a retro-
spective cohort study of adult patients who were admitted 
to participating hospital sites between January 2010 and 
December 2013. The AKI cases will be identified by applying 
the UK laboratory-based algorithm to the linked data from 
laboratory and inpatient systems. The study will aim to: (1) 
determine the incidence of AKI applying a laboratory-based 
algorithm on the linked dataset, and (2) identify any AKI 
cases that may have been missed by comparing the algorithm 
findings to AKI status as recorded in the International Statis-
tical Classification of Diseases and Related Health Problems, 
Tenth Revision, Australian Modification (ICD-10-AM) codes.
This and additional retrospective studies will answer 
questions such as whether different critical test thresholds 
(and the consequent notification processes, eg, direct 
phone call to a clinician vs passive alerting in the form of 
an asterisked result) have any significant association with 
a range of patient process or outcome indicators such 
as length of stay, readmission or mortality. These find-
ings will inform interventions projected by NSW Health 
Pathology to be developed within the test-management 
governance checklist framework in study 1, such as the intro-
duction of new mobile or desktop technology to promote 
the notification and acknowledgement of test results 
or the development of context-specific frameworks for 
identification and notification of results based on critical 
risk, for example, abnormal, life-threatening and so on. 
We will then investigate differences in a range of process 
and outcome indicators for these patients, including time 
taken for notification of pending/completed/verified 
test results, time taken to access and acknowledge test 
results, retest rates, time to ED disposition decision, ED 
length of stay, mortality and readmission rates.
A previous project conducted in collaboration with 
NSW Health Pathology across six hospitals in SES and IS 
LHDs led to the development and extensive utilisation 
of a dataset linking patient demographics, their clin-
ical information, test results and outcomes. This linked 
dataset incorporated some 2.8 million pathology tests 
(from the LIS), 147 280 inpatient admissions (from PAS) 
and 176 015 ED presentations (from the ED information 
system, FirstNet).37 41 We anticipate a larger sample size 
for this study as we will incorporate additional data from 
ICUs andradiology information systems into the linked 
dataset.
Controlled before-and-after study across three EDs
To measure the effects of a range of possible test-result 
follow-up intervention(s) on care process and outcome indi-
cators (to be decided in conjunction with our relevant stake-
holders), we will conduct a controlled before-and-after study 
across three EDs, with two ED sites receiving the same inter-
vention(s) and one control ED site. The study will measure 
the effects of interventions, eg, changes to critical test defini-
tions, notification processes and changed modes of communication 
(eg, fax, pager, telephone or electronic alert) and clinical 
governance processes (eg, escalation process in cases where a 
doctor is not available), on the treatment of patients and 
their clinical outcomes. The study will concentrate on a set 
of laboratory results (eg, sodium, potassium, lactate, creati-
nine, magnesium) where the results are either: (1) critical 
and signify a pathophysiological state that is potentially life 
threatening, or (2) may result in significant patient morbidity, 
irreversible harm or mortality. The study will involve a retro-
spective clinical review of patient records carried out by two 
trained clinical practitioners (eg, nurses) over 2 months in 
years 3 and 5 of the project. The primary outcome measure 
will be the number of critical results reported, acknowledged and 
reviewed alongside the number where no acknowledgement 
is recorded. The study will also consider secondary outcome 
measures including: (1) the method by which these results 
were communicated to and acknowledged by ED medical 
practitioners, (2) the number of incidents of missed diag-
nosis and failure to act associated with unacknowledged 
(likely missed) test results, (3) the treatment (and time to 
treatment) associated with different critical test results, (4) 
the impact on patient outcomes eg, death, length of stay, 
discharge status (ie, transfer, admission to hospital or home) 
or re-presentation within 28 days.
A systematic review showed that the lack of follow-up of 
test results can reach up to 75% in EDs.2 Another study 
reported an acknowledgement rate of 45% for test results 
within critical values in EDs.42 Based on these data, we 
estimate that to detect a 20% change in the acknowledge-
ment rate we require a sample size of 700 critical test 
results across each study period for each study site, and 
another 700 tests during each (2 months) study period 
for each control site, based on a two-sided test of propor-
tions (alpha=0.05, power=0.9; table 2). Previous work 
examining test follow-up in the ED has confirmed the 
feasibility of this sample size.43
Study 3
Aim: Enhance the contribution of consumers to the 
establishment of safe and effective test-result manage-
ment systems.
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This study adopts the philosophy of doing with rather than 
doing for, and is aimed at ensuring consumer involvement in 
all stages of the project from inception to dissemination. We 
sought advice from consumer representative organisations 
during the development of the research grant proposal 
(2014–2015). This collaboration focused on the role of 
patients in improving test-result management systems, and 
showed that the level of patient involvement in their care 
may be influenced by a number of factors, including health 
literacy levels, and access to appropriate tools, and educa-
tional and decision support aids.44
We will adopt three approaches to increase the oppor-
tunity for contribution by consumers, including both 
health consumer representatives and front-line patients, 
across all aspects of the qualitative and quantitative studies 
incorporated in this mixed-methods project, ranging from 
governance to shaping the research direction, interpreta-
tion of findings and the development of revised test-man-
agement governance processes. To this end, we will (1) 
conduct semistructured interviews with ED patients, 
(2) establish consumer reference groups (CRGs) and 
(3) conduct community forums.
Semistructured interviews with ED patients
To provide insights on test-result management processes 
and gain an additional consumer viewpoint, we will 
conduct semistructured interviews with adult patients 
accessing services in EDs across the study sites. Clini-
cians will identify eligible patients in the ED who under-
went a pathology or imaging test. These patients will be 
approached and invited to participate in audio-recorded 
semistructured interviews. Interviews will be designed 
to cover their experiences regarding test-result manage-
ment and result access during the current encounter, 
and more generally, to gauge their views about access 
to their personal health information in relation to test 
results. This will involve identifying the needs of patients 
to determine how pathology and medical imaging results 
are presented, what information is needed to ensure 
that results are easy to access and understand, and guide 
patient-centred decision-making. Semistructured inter-
views with ~20 participants at each selected site are antici-
pated to last ~5 min and will be audio-recorded. Questions 
will be informed by current literature and updated in line 
with emerging findings from the other arms of the study. 
Transcripts of recordings will be used for thematic anal-
ysis. It is envisioned that consumers will be engaged in 
thematic analysis of these data. All qualitative data anal-
ysis in study 3 will be undertaken using the same software, 
methods and measures for trustworthiness outlined for 
study 1.
Consumer reference group
To enhance the contribution of consumers to safe test-re-
sult management, including the direct transmission of 
test results to patients, we will establish a CRG which 
engages health consumer representatives in the gover-
nance structure and all research phases of the project. 
Trained health consumer representatives for the CRG 
will be recruited via health consumer organisations (eg, 
Health Consumers NSW and LHDs) and include other 
key stakeholders (eg, Clinical Excellence Commission, 
Royal College of Pathologists of Australasia (RCPA). The 
CRG will provide feedback about the way that the study 
findings impact on aspects of patient care to help shape 
the direction of the research programme and inform the 
design of informational and educational tools to advance 
consumer engagement.
Community forums
To consider findings from the research and emerging issues 
concerning the safety and quality of care as related to test-re-
sult management (eg, possible impact of innovations such as 
the clinical governance checklist on work processes), members 
of the CRG will also be invited to participate in community 
forums to bring together 10 – 15 participants from major 
community stakeholders (including consumer groups, 
health professionals, IT vendors and healthcare organisa-
tions). A minimum of two forums will be held until project 
completion, and participants will be invited to discuss the 
research findings and help shape their translational capacity 
and diffusion across the healthcare community. Health 
consumer representatives will be reimbursed for their time 
at a rate of $AUD40 (as per nominated reimbursement 
rates)45 for each CRG meeting they attend. At CRG meet-
ings, data will be collected in the form of observational field 
notes and audio recordings, and transcripts of recordings 
will be used for thematic analysis. This information will be 
used to include the consumer perspective in the interpreta-
tion of findings and identify direction for further research.
ExPECtEd outCoMEs And sIgnIfICAnCE
The translation of the findings from this study will help 
organisations address key issues related to the manage-
ment and accountability of test-result management 
systems across all organisational levels. Our research 
engagement with our collaborating partners will generate 
evidence about the safety and effectiveness of major 
test-result follow-up interventions across laboratories, 
medical imaging departments and hospitals. The study 
will contribute to: (1) improved hospital care and health 
service delivery, (2) the development of healthcare guide-
lines to improve the delivery of safe and quality care, 
(3) improved end-user accessibility and involvement in 
health services and (4) increased health system capacity.
Study 1 will adopt a qualitative approach to map the 
test-result management and notification processes across 
eight study sites. This study will describe the multiple 
processes used to manage test results across seven adult 
hospitals and a children’s hospital. Study 1 will produce 
a test-result management clinical governance checklist which 
represents a substantial contribution to the establishment 
of resilient governance structures that promote account-
ability in how test results are managed within and across 
healthcare settings. The checklist will help healthcare 
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organisations achieve the best possible patient outcomes 
using governance systems that can track and monitor 
results and ensure that they are acted on when needed.
Study 2 will take a highly innovative data-driven 
approach to generate evidence regarding the rela-
tionships between critical test results (eg, results that 
reach a threshold defined as ‘critical’) and notifica-
tion practices (eg, the time between the issuing of a 
critical result and when the clinician receives and/or 
views the result), and a range of patient process and 
outcome indications (eg, length of stay, mortality). 
Such an approach has not been undertaken previ-
ously on such a large scale for a range of tests and 
patient groups. The results of this aspect of the study 
will provide evidence across multiple hospitals about 
the effects of interventions on: (1) the number and 
type of critical results that are received, acknowledged 
and acted on; (2) the percentage of critical results 
and their thresholds which lead to specific actions and 
(3) the resultant impact on patient treatment and 
outcomes.
Study 3 is founded on the active involvement of 
consumers who will contribute to the design and 
implementation of major interventions (including 
eHealth applications) to enhance consumer engage-
ment into the future.46 We will adopt multiple strate-
gies to capture the experiences and opinions of trained 
health consumer representatives and ED patients 
covering all aspects and stages of the study from incep-
tion to dissemination, and from governance to inter-
pretation of study findings.
EtHICs And dIssEMInAtIon
The release of non-identifiable unit record data for 
research purposes has been approved by the Centre for 
Epidemiology and Evidence, NSW Ministry of Health.
All participants in study 1 and study 3 will provide written 
informed consent. These participants will not be asked for 
their identity. Identifying information that could be coin-
cidentally revealed during interviews/focus groups will be 
de-identified during transcription or deleted from photo-
graphs and artefacts. The identity of participants will not be 
disclosed in the reporting of the results.
The privacy and identities of individuals described in 
the datasets used in study 2 will be protected by using 
a non-identifiable dataset. Only results aggregated at 
a high level will be reported. In the unlikely event of 
a result that describes a small number of individuals, 
statistical disclosure control methods (NSW Health, 
Privacy Issues and the Reporting of Small Numbers, 
September 2011) will be implemented to avoid the 
inadvertent inferential disclosure of individual iden-
tities. These methods include collapsing cells, cell 
suppression and cell modification, where appropriate. 
All reported results will meet a conservative minimum 
k>10 individuals threshold limit for ‘small cells’. While 
the dataset could potentially be reidentified, the 
coding used will be stored by NSW Health Pathology 
and will not be revealed to the researchers.
The project is funded under an NHMRC Partnership 
Project grant with local and national partners at clinical 
and policy levels. Funding partners include NSW Health 
Pathology, and the Australian Commission on Safety 
and Quality in Health Care. Other stakeholders include 
Health Consumers NSW, AACB, and RCPA. The study 
team includes academic researchers, hospital and labo-
ratory clinicians, and senior policy-makers from national 
health and clinical agencies.
In the first instance, study findings will be reported at 
executive level at the hospital sites and to partners in a 
series of workshops to identify specific areas for inter-
vention or to address any major safety or process issues 
related to test-result management. In addition, find-
ings will be disseminated to a diverse audience through 
peer-reviewed academic literature, popular science 
communications, industry and consumer newsletters and 
journals, and at academic, industry and health consumer 
conferences. Given the diversity of the project team, 
further options for dissemination of results include trans-
lational and implementation strategies such as the inclu-
sion of findings in the development of policy or health 
information systems.
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